Impax Asset Management Group PLC Sarepta Therapeutics, Inc. Put Options Transaction History
Impax Asset Management Group PLC
- $15.6 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
486Shares Held
91.4MCall Options Held
1.39MPut Options Held
1.15M-
Black Rock Inc. New York, NY10.3MShares$188 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$165 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$165 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$74.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$61.3 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...